Tag: sars-cov-2
EMA Vaccine Strategy Chief Marco Cavaleri: “increasingly difficult to say that there is no cause and effect relationship between vaccination with AstraZeneca and very rare cases of unusual blood clots”
Marco Cavaleri is responsible for the vaccine strategy of EMA, the European drug agency. More...
Ireland: HPRA has received 16 reports of blood clots occurring following vaccination with the AstraZeneca coronavirus vaccine
Ireland’s Health Products Regulatory Authority (HPRA) has said it has received 16 reports of blood clots occurring following vaccination with the AstraZeneca Covid-19 vaccine. More...
Switzerland: Stage III hypertension in patients after mRNA-based SARS-CoV-2 coronavirus vaccination with Pfizer/Biontech & Moderna
On January 11th 2021, the vaccination Center in Lausanne, a city of 140’000 inhabitants in western Switzerland, started the COVID-19 vaccination with mRNA-based vaccines. More...
Chile heads back into coronavirus lockdown despite massive vaccination campaign with Sinovac vaccine
Chile’s big coronavirus vaccine bet on China’s Sinovac shots. More...
L452R mutation is present in more than 400 SARS-CoV-2 coronavirus genomes isolated from over 20 countries
Scientists have examined the Nextstrain and GISAID databases and found that the L452R mutation is present in more than 400 SARS-CoV-2 genomes isolated from over 20 countries. More...
Transmission of SARS-CoV-2 coronavirus in domestic cats may have accelerated the fixation of S H655Y
Transmission of SARS-CoV-2 in cats involved a narrow bottleneck, with new infections founded by fewer than ten viruses. More...
France: coronavirus VOI 19B/501Y, aka HMN.19B or Henri Mondor variant could be a reinfection risk
The VOI 19B / 501Y (lineage A.27) has been detected infrequently but regularly in France since January 2021. More...
Rapid rise of coronavirus SARS-CoV-2 spike mutation T478K found in Mexico and several European countries
We report the distribution of the Spike mutation S:T478K and its recent growth in prevalence in the SARS-CoV-2 population. More...
ONS: Prevalence of Long Haul symptoms following coronavirus (COVID-19) infection in the UK
Among a sample of over 20,000 study participants who tested positive for COVID-19 between 26 April 2020 and 6 March 2021, 13.7% continued to experience symptoms for at least 12 weeks. More...
Canada: coronavirus variant P.1 outbreak spreads to Alberta
“We are currently investigating a significant #COVID19AB outbreak in Alberta involving P.1 variants of concern (the variant that originated in Brazil), linked to a returning traveller.” More...